• An estrogen receptor–immunocytochemical assay (ER-ICA) was performed on frozen
sections of 130 samples of human breast carcinoma. A standard dextran-coated charcoal …

ŽP Marinšek, N. Nolde, I. Kardum‐Skelin, R. Nizzoli, B. Önal, T. Rezanko, E. Tani, KT
Ostović, P. Vielh, F. Schmitt and G. Kocjan Multinational study of oestrogen and …

Estrogen and progesterone receptor reactivity may be useful in identifying possible primary
sites of metastatic disease or directing therapy in tumors of the female genital tract, including …

Assessment of heterogeneity in oestrogen receptor (ER) expression aims to improve
prediction of prognosis and treatment assignment in breast cancer. Current assessments are …

An immunocytochemical assay using a monoclonal antibody specific for estrogen receptor
(ER-ICA) was performed on needle aspirates and on histologic sections (mastectomy and …

Monoclonal antibodies were used for a preoperative analysis of estrogen receptors (ERs)
and progesterone receptors (PgRs) in fine‐needle aspirates from 44 primary human breast …

Fine-needle aspirates (FNAs) of 84 primary breast carcinomas were analyzed
immunocytochemically for estrogen receptor (ER) using (ER-ICA) monoclonal antireceptor …

A methodology, originally built up in our laboratory, for the simultaneous determination of
estrogen (ER) and progesterone (PR) receptors on small samples of tumor tissues [1], has …

For 56 cases of carcinoma of the breast, results of the immunocytochemical assay for
estrogen and progesterone receptors performed on preoperative fine-needle aspirates were …

The estrogen receptor (ER) content of breast carcinoma is generally accepted as valuable in
predicting clinical outcome and tumour response to hormonal manipulation. We applied a …